Atrion Reports Second Quarter 2020 Results

Atrion Corporation announced that for the second quarter ended June 30, 2020, revenues totaled $38.0 million compared with $40.1 million for the same period in 2019.

ALLEN, Texas, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that for the second quarter ended June 30, 2020, revenues totaled $38.0 million compared with $40.1 million for the same period in 2019. Net income for the second quarter of 2020 totaled $8.6 million as compared to $9.7 million for the same period in 2019, with diluted earnings per share for the second quarter of 2020 at $4.68 compared to $5.18 for the second quarter of 2019.

Commenting on the Company’s quarterly results for the second quarter of 2020 compared to the same period last year, David A. Battat, President & CEO, stated, “The impact of the pandemic was felt in the second quarter with revenues and operating income lower by 5% and 8%, respectively, essentially the reverse image of the first quarter when revenues were up 5% and operating income was up 6%.” Mr. Battat explained, “The current year second quarter saw hospitals suspend elective surgeries to preserve ICU beds and other resources to deal with the anticipated deluge of Covid-19 patients. As a result, sales of our products used in elective procedures were lower by $3.7 million.” Mr. Battat added, “The net impact on overall sales was limited to $2.1 million thanks to our diversified product portfolio and the tireless efforts of my co-workers who kept our operations running throughout this period.”

Mr. Battat continued “With an effective tax rate 15% higher in this year’s quarter than the prior year’s second quarter, diluted EPS and net income were lower by 10% and 11%, respectively. During the quarter we purchased 12,158 shares of our common stock at an average cost of $641 per share. As of June 30, 2020, we continue to be debt free while holding $87.5 million in cash and short and long term investments.”

Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is www.atrioncorp.com.

 

ATRION CORPORATION
UNAUDITED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)

  Three Months Ended
June 30,
  Six Months Ended
June 30,
    2020       2019       2020       2019  
Revenues $ 37,968     $ 40,103     $ 81,563     $ 81,717  
Cost of goods sold   20,499       21,511       44,226       44,422  
Gross profit   17,469       18,592       37,337       37,295  
Operating expenses   7,423       7,626       15,577       15,291  
Operating income   10,046       10,966       21,760       22,004  
               
Interest and dividend income   367       581       858       1,163  
Other investment income (loss)   354       161       (673 )     372  
Income before income taxes   10,767       11,708       21,945       23,539  
Income tax provision   (2,162 )     (2,044 )     (4,443 )     (4,437 )
Net income $ 8,605     $ 9,664     $ 17,502     $ 19,102  
               
Income per basic share $ 4.69     $ 5.21     $ 9.49     $ 10.30  
               
Weighted average basic shares outstanding   1,835       1,854       1,844       1,854  
               
               
Income per diluted share $ 4.68     $ 5.18     $ 9.47     $ 10.25  
               
Weighted average diluted shares outstanding   1,839       1,864       1,849       1,863  

 

ATRION CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands)

  June 30,   Dec. 31,
ASSETS 2020   2019
  (Unaudited)    
Current assets:      
Cash and cash equivalents $ 24,099   $ 45,048
Short-term investments   6,574     23,766
Total cash and short-term investments   30,673     68,814
Accounts receivable   22,441     18,886
Inventories   45,805     42,093
Prepaid expenses and other   3,226     2,545
Total current assets   102,145     132,338


Long-term investments
  56,871     31,772


Property, plant and equipment, net
  87,867     84,606
Other assets   13,467     13,315
       
  $ 260,350   $ 262,031
       
       
LIABILITIES AND STOCKHOLDERS’ EQUITY      
       
Current liabilities   15,443     11,274
Line of credit   --     --
Other non-current liabilities   11,380     12,887
Stockholders’ equity   233,527     237,870
       
  $ 260,350   $ 262,031

Contact:
Jeffery Strickland
Vice President and Chief Financial Officer
(972) 390-9800

Primary Logo

MORE ON THIS TOPIC